Physician

Andrew T Johnson, M.D.

According to 2025 Medicare claims, Andrew Johnson, M.D. (NPI: 1497045553) practices hematology/oncology in the Gainesville, GA market, with the plurality of this provider's patient population coming from Hall, GA. This provider's primary affiliated billing organization is THE LONGSTREET CLINIC, PC (NPI: 1326019977; TIN: 582117020) and primary practice location at 30501-3834.

Johnson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 448 traditional Medicare patients, billed 153,278 HCPCS/CPT codes, and received $2,754,910 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,565 prescription claims across 336 beneficiaries totaling $4,433,413 in drug costs, led by Lenalidomide (Lenalidomide). DME data shows 189 claims. Open Payments data shows 160 records totaling $233,016. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $8,312 to $2,754,910. Similarly, Part D prescription costs have moved sharply higher in recent years, from $5,756 to $4,433,413. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $4,516 to $18,229.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	73	98	$8,312
2017	104	7,696	$188,584
2018	185	63,469	$733,086
2019	233	110,652	$1,174,966
2020	276	150,419	$1,447,673
2021	332	157,849	$2,696,069
2022	315	115,554	$2,437,414
2023	348	129,624	$2,436,703
2024	448	153,278	$2,754,910

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	14	27	$5,756
2017	48	135	$3,474
2018	134	711	$303,833
2019	151	1,190	$1,031,246
2020	209	1,658	$1,276,035
2021	252	1,777	$2,036,241
2022	269	1,956	$3,082,147
2023	283	2,164	$3,386,456
2024	336	2,565	$4,433,413

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	91	$3,967
2019	N/R	36	$674
2020	N/R	14	$1,399
2021	N/R	71	$5,262
2022	N/R	81	$4,265
2023	N/R	84	$9,912
2024	126	189	$27,794

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	365	1,184	$89
G0444	Annual depression screening, 5 to 15 minutes	180	180	$17
80053	Blood test, comprehensive group of blood chemicals	277	944	$10
36415	Insertion of needle into vein for collection of blood sample	297	1,091	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	283	981	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lenalidomide	Lenalidomide	46	1,288	$685,604
Pomalyst	Pomalidomide	26	721	$569,458
Tagrisso	Osimertinib Mesylate	28	840	$462,778
Kisqali	Ribociclib Succinate	28	784	$417,131
Revlimid	Lenalidomide	21	588	$376,980

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
L8030	Breast prosthesis, silicone or equal, without integral adhesive	N	38	38	$14,969
L8000	Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type	N	74	97	$9,578
A6578	Gradient compression arm sleeve, each	N	14	17	$1,238
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	13	$1,024
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	12	$559

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	157	$3,998	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	3	$229,018	Amgen Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Andrew T. Johnson, M.D.?

Tedicare shows public-source Medicare data for Andrew T. Johnson, M.D. (NPI 1497045553), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew T. Johnson, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Andrew T. Johnson, M.D.?

Andrew T. Johnson, M.D. is linked to THE LONGSTREET CLINIC, PC (billing NPI 1326019977) in the available physician profile data.

Does Andrew T. Johnson, M.D. have Open Payments data?

Andrew T. Johnson, M.D. has 160 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.